Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 9.5B | 9.1B | 8.8B | 8.4B |
| Cost of revenue | 4.6B | 4.5B | 5.0B | 4.4B |
| Gross profit | 4.9B | 4.5B | 3.9B | 4.0B |
| Operating expense | ||||
| Research & development | 709.0M | 707.4M | 667.6M | 631.9M |
| Selling general and admin | 992.5M | 954.1M | 1.2B | 911.5M |
| Other operating expenses | — | — | — | — |
| Operating income | 3.2B | 2.9B | 2.0B | 2.5B |
| Non operating interest income | ||||
| Income | 34.1M | 43.8M | 46.5M | — |
| Expense | 157.0M | 158.3M | 165.6M | 177.5M |
| Other income expense | — | — | — | — |
| Pretax income | 3.1B | 2.8B | 1.8B | 2.3B |
| Tax provision | 435.2M | 278.0M | 228.4M | 291.8M |
| Net income | 2.7B | 2.5B | 1.6B | 2.0B |
| Basic EPS | 7.4 | 6.8 | 4.4 | 5.5 |
| Diluted EPS | 7.2 | 6.6 | 4.3 | 5.4 |
| Basic average shares | 365.6M | 367.3M | 367.7M | 368.2M |
| Diluted average shares | 373.9M | 375.7M | 376.4M | 376.5M |
| EBITDA | 6.6B | 6.3B | 5.6B | 5.8B |
| Net income from continuing op. | 2.7B | 2.5B | 1.6B | 2.0B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |